Home » Topics » Regulatory

Regulatory
RSS

Nonapprovable letter issued for Casodex in early prostate cancer

June 27, 2002

Metformin XT is equivalent to immediate-release metformin in the treatment of type 2 diabetes

June 27, 2002

Ethypharm and Viatris collaborate on Flashtab formulation of tramadol

June 25, 2002

Australia first to approve Xolair

June 21, 2002

FDA approves Celebrex labeling changes

June 18, 2002

Japanese approval obtained for Elaspol

June 18, 2002

Extina enters phase III for seborrheic dermatitis

June 17, 2002

Zyprexa approved in E.U. for manic episodes associated with bipolar disorder

June 17, 2002

Phase II results announced for Ciprofloxacin GR

June 14, 2002

FDA approves Ritalin LA for ADHD

June 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...